Clinical Trials
According to clinicaltrials.gov under the U.S. National Institutes of Health, the EU Clinical Trials Register, and the International Clinical Trials Registry Platform under the World Health Organization (WHO), the following trials are currently or soon to be recruiting (as of 24 November 2024).
Read more about these and other clinical trials at:
HAELO: a Phase 3 Study to Evaluate NTLA-2002 in Participants with Hereditary Angioedema (HAE)
United States
https://clinicaltrials.gov/study/NCT06634420A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
Belgium, Bulgaria, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Turkey, United Kingdom, United States
https://clinicaltrials.gov/study/NCT05392114A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People (SPEAKUP)
No sites confirmed
https://clinicaltrials.gov/study/NCT06587464A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland
Poland
https://clinicaltrials.gov/study/NCT05147181C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Bulgaria, Croatia, Czechia, France, Germany, Hungary, Italy, North Macedonia, Norway, Poland, Slovakia, Slovenia, Sweden
https://www.clinicaltrials.gov/study/NCT01397864A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)
United Kingdom
https://clinicaltrials.gov/study/NCT05469789A Survey of Lanadelumab in Participants With Hereditary Angioedema
Japan
https://clinicaltrials.gov/study/NCT05397431A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema
Japan
https://clinicaltrials.gov/study/NCT05509569A Study of STAR-0215 in Participants With Hereditary Angioedema
Bulgaria, Canada, Czechia, Germany, United Kingdom, United States
https://clinicaltrials.gov/study/NCT05695248A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
United States, Canada
https://www.clinicaltrials.gov/study/NCT06007677PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
Australia, Austria, Bulgaria, France, Germany, Greece, Israel, Japan, Netherlands, New Zealand, Spain, United Kingdom, United States
https://clinicaltrials.gov/study/NCT05511922CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema
Israel, United States
https://clinicaltrials.gov/study/NCT05819775An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
Australia, Austria, Bulgaria, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, North Macedonia, Poland, Portugal, Slovakia, South Africa, Spain, United Kingdom, United States
https://clinicaltrials.gov/study/NCT05505916Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Bulgaria, Canada, Czechia, France, Germany, Hungary, Israel, Poland, Spain, United States
https://clinicaltrials.gov/study/NCT05396105Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema (RAPIDe-3)
United States, Puerto Rico
https://www.clinicaltrials.gov/study/NCT06343779Status of Dental Care Practices in Patients With Hereditary Angioedema
France
https://clinicaltrials.gov/study/NCT05776784Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C-1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
United States, Armenia, Bulgaria, Mexico, Peru, Romania, Serbia, Ukraine
https://www.clinicaltrials.gov/study/NCT06361537Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
Australia
https://clinicaltrials.gov/study/NCT05691361Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
France, New Zealand, United Kingdom
https://www.clinicaltrials.gov/study/NCT06262399A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr) in Persons With HAE in China
China
https://clinicaltrials.gov/study/NCT06346899Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) with HAE Type I or II (KONFIDENT-KID)
United States
https://clinicaltrials.gov/study/NCT06467084Institutional Registry of Rare Diseases
Argentina
https://www.clinicaltrials.gov/study/NCT06573723Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE (CHAPTER-3)
No location data
https://www.clinicaltrials.gov/study/NCT06669754Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults with HAE (CHAPTER-4)
No location data
https://www.clinicaltrials.gov/study/NCT06679881Angioedema Biomarker Research Study
No location data
https://www.clinicaltrials.gov/study/NCT06210698Identification and Characterization of Genetic Variants in Hereditary Angioedema (GENOMAEH_01)
HAE related topics that might interest you
Global Perspectives
Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community
HAEi Advocacy Academy
Courses, advocacy training, and tools to support people living with HAE and becoming an HAE advocate
HAEi Connect Member database
Free, secure online membership database and communications platform for HAEi’s member organizations
HAE Companion app
Access to HAEi’s emergency card in many languages and ACARE Centers, HAE knowledgeable hospitals and physicians
Stay tuned – sign up for our newsletter
BE THE FIRST TO KNOW ABOUT HAE NEWS, TREATMENTS, EVENTS AND RELATED TOPICS